Stocks in news: Infosys, United Spirits, Gufic Biosciences, Alkem Labs, Bharat Forge
Infosys
Infosys said it will consider an interim dividend along with its second quarter results, which will be announced on October 12.
United Spirits
Following an order passed on applicability of GST rate on royalty income, the company has filed an appeal before Joint Commissioner Of Commercial Taxes (Appeals-1).
Read more: Here's the trading setup for today's session
SeQuent Scientific
The company's Board has approved the sale of API facility in Thane.
Gufic BiosciencesThe company has been granted patent for an invention entitled “A Freeze Dried Parenteral Composition Of Omadacycline Tosylate And Process For Preparation Thereof for the term of 20 years effective from April 19, 2021.
Alkem Labs
Alkem Labs said the income tax department has conducted a survey at some of its offices and subsidiaries.
The company said it is fully cooperating with the officials of the IT department and are responding to the queries raised by them.
NTPC
NTPC Limited has signed a supplementary joint venture agreement with UP Rajya Vidyut Utpadan Nigam.
Strides Pharma
Strides Pharma Science announced that its stepdown wholly owned subsidiary, Strides Pharma Global Pte has received tentative approval for Dolutegravir 50mg tablets from USFDA.
Bharat Forge
Paramount announced a broadening of its development and manufacturing partnership with Bharat Forge and Kalyani Strategic Systems, to produce a wider range of armoured vehicles in India for Paramount’s global customers.
Patel Engineering
Patel Engineering has been declared for a Rs 249.96 crore contract for the works involving construction of pipe line distribution network for Nira Deoghar Right Bank Main Canal.
Adani Enterprises
Adani Enterprises' unit Adani Wind's 5.2 MW wind turbine enlisted in MNRE list of
